Annual report pursuant to Section 13 and 15(d)

Balance Sheet Components - Components of Accrued Liabilities (Detail)

v3.20.4
Balance Sheet Components - Components of Accrued Liabilities (Detail) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Accrued Liabilities Current [Abstract]    
General and administrative $ 1,577 $ 4,521
Clinical trial related costs 1,743 1,383
Non-clinical research and manufacturing operations 4,321 5,774
Payroll related 4,908 2,849
Other accrued expenses 26 17
Total Accrued liabilities $ 12,575 $ 14,544